Jul 14, 2026 08:01AM
Jul 14, 2026 08:00AM
Jun 26, 2026 08:02AM
Jun 26, 2026 08:00AM
May 15, 2026 04:15PM
May 12, 2026 08:09AM
May 12, 2026 08:00AM Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
May 8, 2026 08:00AM
Apr 16, 2026 08:04AM
Apr 16, 2026 08:00AM
Apr 9, 2026 06:13AM
Apr 7, 2026 08:17AM
Apr 7, 2026 08:00AM
Mar 31, 2026 06:51AM Ensysce Biosciences (ENSC) Misses Q4 EPS by 75c
Mar 30, 2026 04:50PM
Mar 4, 2026 08:45AM
Mar 3, 2026 08:02AM
Mar 3, 2026 08:00AM
Feb 25, 2026 08:00AM
Feb 23, 2026 08:00AM
Jan 28, 2026 08:02AM Ensysce reaches 50% enrollment in phase 3 trial for opioid PF614
Jan 28, 2026 08:00AM
Jan 21, 2026 08:03AM
Jan 21, 2026 08:00AM
Jan 8, 2026 08:00AM
Jan 5, 2026 08:03AM
Jan 5, 2026 08:00AM
Dec 9, 2025 08:00AM Ensysce begins Phase 3 trial enrollment for pain drug PF614
Dec 9, 2025 08:00AM
Dec 2, 2025 08:05AM
Dec 2, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 17, 2025 08:06AM
Nov 17, 2025 08:05AM Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
Nov 16, 2025 11:46PM
Nov 14, 2025 04:15PM
Sep 4, 2025 08:00AM
Aug 19, 2025 08:00AM
Aug 13, 2025 06:15PM
Aug 13, 2025 04:15PM
Jul 31, 2025 08:00AM Ensysce receives FDA guidance on opioid with overdose protection
Jul 31, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jun 24, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 4, 2025 08:12AM
Jun 4, 2025 08:00AM Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection
May 14, 2025 04:58PM

427,714 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All